The preclinical study is the first to use a pneumonia vaccine that is on the market, instead of a model antigen, to study the immune response triggered by the vaccine.
UB scientists offer data that show that if they're deployed widely, behaviors like mask-wearing can help avoid outbreaks like those in the South and West.